JPX:4599

StemRIM · JPX · Healthcare · JPY · FY for 2026

Figures on this page computed 2026-11-08 13:29 UTC

Last close

n/aJPY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed

4 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Then and now

lens 3 of 9

Five filed facts, 2017 against 2026.
Fact	2017	2026	Change
Sales	300,000,000	n/a	n/a
Profit	-123,936,000	-1,851,498,000	-1,394%
Free cash flow	-285,347,000	-1,617,556,000	-467%
Debt	n/a	n/a	n/a
Shares in issue	50,282,700	62,483,983	+24.3%

The same five facts for 2017 and 2026, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2017

Sales, 2017300,000,000
Source
computed
Statement
income
Fiscal year
2017
Reported in
JPY
Sales, 2026n/aComputed from the filing for 2026
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Profit, 2017-123,936,000
Source
computed
Statement
income
Fiscal year
2017
Reported in
JPY
Profit, 2026-1,851,498,000Computed from the filing for 2026
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Free cash flow, 2017-285,347,000
Source
computed
Statement
income
Fiscal year
2017
Reported in
JPY
Free cash flow, 2026-1,617,556,000Computed from the filing for 2026
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Debt, 2017n/a
Not held.
Source
computed
Statement
income
Fiscal year
2017
Reported in
JPY
Debt, 2026n/aComputed from the filing for 2026
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Shares in issue, 201750,282,700
Source
computed
Statement
income
Fiscal year
2017
Reported in
JPY
Shares in issue, 202662,483,983Computed from the filing for 2026
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY